Stocktoria

Burning Rock Biotech Ltd BNR

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2020-06-12

Burning Rock Biotech Ltd statistics & valuation

Profitability & efficiency

Net margin (%)
-44.30% -94.70% -156.90% -172.40% -121.60% -67.20% -10.30% 2019202020212022202320242025
Gross margin (%)
71.60% 73.00% 71.70% 67.50% 67.60% 70.30% 74.70% 2019202020212022202320242025
Operating margin (%)
-44.30% -95.90% -156.90% -174.10% -124.50% -69.30% -10.20% 2019202020212022202320242025
Return on equity (%)
-16.80% -43.20% -83.80% -85.10% -59.70% -10.30% 2019202020212022202320242025
Shares outstanding
25.0M 0 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-20.00% -15.30% -35.00% -61.20% -62.90% -39.20% -6.70% 2019202020212022202320242025
Free cash flow margin (%)
-71.00% -31.10% -134.30% -92.10% -49.10% -18.90% -6.20% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin74.7%70.3%67.6%67.5%71.7%73.0%71.6%
Operating margin-10.2%-69.3%-124.5%-174.1%-156.9%-95.9%-44.3%
Net margin-10.3%-67.2%-121.6%-172.4%-156.9%-94.7%-44.3%
FCF margin-6.2%-18.9%-49.1%-92.1%-134.3%-31.1%-71.0%
Return on assets-6.7%-39.2%-62.9%-61.2%-35.0%-15.3%-20.0%
Return on equity-10.3%-59.7%-85.1%-83.8%-43.2%-16.8%19.0%
Current ratio2.992.923.363.064.8910.454.30

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.